Christine Monateri v. Commissioner of Social Security

436 F. App'x 434
CourtCourt of Appeals for the Sixth Circuit
DecidedAugust 11, 2011
Docket09-4524
StatusUnpublished
Cited by32 cases

This text of 436 F. App'x 434 (Christine Monateri v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Christine Monateri v. Commissioner of Social Security, 436 F. App'x 434 (6th Cir. 2011).

Opinion

CLAY, Circuit Judge.

Plaintiff Christine Monateri appeals an order affirming the Social Security Commissioner’s decision denying her application for social security disability and supplemental security income benefits.

For the reasons set forth herein, we AFFIRM the district court’s decision.

FACTUAL BACKGROUND

I. Medical and Employment History

At the time that she filed applications for Social Security Disability (“SSD”) and Social Security Income (“SSI”), Claimant Christine Monateri was a 47-year old woman, who had a history of semi-skilled sedentary work and was a high school graduate with one year of college and a certificate in accounting. Prior to her disability onset date, Monateri worked steadily as a secretary, an accounts receivable clerk and a collections clerk.

In February 1999, Monateri had what she describes as a “breakdown” and was hospitalized. After her release, she returned to work at her then-employer Morrison Products, where she remained until November 1999, when she had a second breakdown. At that time, she was terminated from her job at Morrison.

*436 In February 2000, Monateri began mental health treatment at Pathways Mental Health Center in Mentor, Ohio. She was initially assessed by psychiatrist Dr. Farid Sabet, whose notes document his impression that Monateri suffered from panic disorder and dysthymia (chronic low-grade depression). It appears from the record that Monateri was already taking Xanax (alprazolam), an anti-anxiety agent, and Prozac (fluoxetine), an anti-depression medication, when she saw Dr. Sabet. He maintained her on the Prozac, but switched her from Xanax to Klonopin (clo-nazepam). A month later, on March 3, 2000, Monateri’s prescription for Prozac was replaced with one for Paxil (paroxe-tine), a selective serotonin reuptake inhibitor (SSRI).

In June 2000, Dr. Kurt Bertschinger, also a psychiatrist at Pathways, began to treat Monateri for her mental disorders. At that time, Dr. Bertschinger completed a “Mental Functional Capacity Assessment” on Monateri, wherein he found her “moderately limited” in 16 of 20 listed work-related areas. He also offered an assessment that she was “unemployable” and that her limitations were expected to last between nine and eleven months.

It appears that Monateri’s condition worsened over the next several months, and by August 2000, Dr. Bertschinger noted the presence of major depressive disorder and generalized anxiety disorder. Dr. Bertschinger noted that Monateri’s condition was improved by the medication, but that her “major life stressors” were continuing. Dr. Bertschinger continued to treat Monateri throughout January 2001, during which time he made several adjustments to her medication.

In July 2001, Monateri had a “psychological consultive examination” with Pathway’s Dr. Kenneth Felker. 1 Dr. Felker diagnosed Monateri with depressive disorder, polysubstance abuse (in remission), and panic disorder without agoraphobia. He concluded that Monateri was impaired in her ability to concentrate, carry out tasks, and relate to others. He also opined that her ability to relate to work peers and supervisors and to tolerate the stress associated with employment was “mildly to moderately” impaired.

The condition of Monateri’s mental health, and the severity of her symptoms, fluctuated throughout 2001. At times, Monateri is noted as having decreased tearfulness, brighter affect, and decreased symptoms of depression, anxiety and panic; at other times, she is noted as “doing okay but not great,” suffering from “periods of depression,” and experiencing “hy-pomanic episodes;” and her response to treatment is noted as ranging from “partial” to “fair.”

The record is silent on Monateri’s medical treatment between December 2001 and February 2003, when Pathway’s psychiatrist Dr. Thomas Svete took over Mona-teri’s care. 2 Dr. Svete’s impression was that Monateri suffered from panic disorder and agoraphobia, and post-traumatic stress disorder and alcohol dependence “by history.” Monateri’s condition appears to have worsened throughout 2003, with Dr. Svete noting that she was “not doing well” and was “severely impaired.” Dr. Svete rated her level of impairment as ranging from a 5 to a 7 (on a scale of 10).

Dr. Svete completed an “Assessment of Ability to Do Work-Related Activities *437 (Mental)” created by Monateri’s attorney on June 11, 2003. 3 On this form, Dr. Svete indicated that Monateri showed “marked impairment” in her ability to: conduct daily activities; maintain concentration and attention for extended periods; sustain a routine without special supervision; perform activities within a schedule, maintain regular attendance, and be punctual; respond appropriately to co-workers; respond to customary work pressures; and respond appropriately to changes in the work setting. He indicated lesser, but still present, limitations in several other categories, including Monateri’s ability to: relate to people; maintain personal habits; understand, carry out, and remember instructions; respond to supervision; use good judgment; perform complex, repetitive, or varied tasks; and behave in an emotionally stable manner. Dr. Svete further opined that Monateri’s condition would be exacerbated by a stressful work environment, and that she might be absent from work as many as three days per week.

On January 7, 2004, Dr. Svete reported that Monateri informed him that she was abusing opiates, and requested admission to a drug detoxification program. On January 10, 2004, Monateri was admitted to Rosary Hall at St. Vincent Charity Hospital for medically supervised opiate and benzodiazepine withdrawal. In addition to abusing her prescribed Xanax, Monateri admitted to abusing Oxycontin, a controlled opiate. Monateri was admitted to Huron Hospital a week later after her discharge from Rosary Hall, for symptoms related to her mental disorders and because she had relapsed on Xanax.

Dr. Svete continued to treat Monateri throughout early 2004 and by May, when Monateri continued to show improvement, had decreased all of her medications. At that time, he reported that Monateri was “doing extremely well,” attending alcoholics anonymous (“AA”) meetings, and had been drug (abuse) free for 60 days. He opined that her conditions were “in early remission” with the exception of her anxiety. By June of 2004, Dr. Svete’s assessment was that Monateri was “mildly ill.”

In August of 2004, Monateri was again admitted to Rosary Hall for drug detox, after relapsing on Oxycontin. 4

In September 2004, Monateri began working full-time as an accounts receivable/collections clerk at Cintas Corporation. On January 26, 2005, Monateri reported to Dr. Svete that the pressure of the job was causing a recurrence of her mental health symptoms. She reported increased anxiety, and also admitted that she had begun abusing Oxycontin again. In addition to his normal treatment, Dr. Svete suggested at this time that Monateri enter therapy and take only prescribed medications.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
436 F. App'x 434, Counsel Stack Legal Research, https://law.counselstack.com/opinion/christine-monateri-v-commissioner-of-social-security-ca6-2011.